Related Experiment Video
Updated: May 23, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Identification of Anoikis-Related Genes in Driving Immune-Inflammatory Responses in Ulcerative Colitis Based on
Wenxiu Diao1,2, Xu Huang1, Wensha Huang1
1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Background:
Ulcerative colitis (UC) is a challenging chronic intestinal inflammation. Anoikis, a type of programmed cell death triggered by detachment from the extracellular matrix, is crucial in various physiological and pathological contexts. This study aims to explore the biological and clinical implications of anoikis-related genes (ARGs) in UC.
Methods:
Gene expression microarrays from normal and UC mucosal tissues focused on ARGs. Differentially expressed genes (DEGs) related to anoikis in UC were identified. Weighted gene co-expression network analysis (WGCNA) screened UC-related module genes. GO, KEGG, GSEA, and GSVA analyses were used to uncover mechanisms. Machine learning identified hub ARG-DEGs highly correlated with UC, and diagnostic nomograms assessed their diagnostic potential. The CIBERSORT algorithm analyzed changes in the UC immune microenvironment related to hub UC-ARGs. Potential drugs, miRNAs, and transcription factors (TFs) interacting with these hub UC-ARGs were investigated, and animal experiments verified their expression.
Results:
49 ARG-DEGs were identified, mainly linked to the PI3K-AKT signaling pathway, inflammatory signal regulation, and extracellular matrix (ECM)-receptor interactions. Notably, CDH3 and SERPINA1 showed significant diagnostic potential for UC, confirmed by the Wilcoxon rank-sum test, independent validation sets, Western blot, and immunohistochemical staining. Significant variations in immune cell infiltration and activation within UC samples correlated with hub UC-ARGs were observed using the CIBERSORT algorithm.
Conclusion:
Anoikis may drive UC progression by initiating an immune inflammatory response. CDH3 and SERPINA1 are promising biomarkers and therapeutic targets for UC.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
The JAK-STAT Signaling Pathway
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...